首页> 外文会议>Society for Biomaterials annual meeting and exposition >Delivery of Bupivacaine and Tolfenamic Acid from Ultra-High Molecular Weight Polyethylene: Multimodal Pain Relief and Synergistic Antibacterial Properties from Total Joint Implants
【24h】

Delivery of Bupivacaine and Tolfenamic Acid from Ultra-High Molecular Weight Polyethylene: Multimodal Pain Relief and Synergistic Antibacterial Properties from Total Joint Implants

机译:从超高分子量聚乙烯中递送布比卡因和甲苯酚酸:全关节植入物的多峰镇痛和协同抗菌性能

获取原文

摘要

Typical post-arthroplasty bolus injections of local anesthetics and NSAIDs range from 30-400 mg and 30 mg, respectively. This study shows that analgesic-loaded UHMWPE can deliver clinically-relevant doses of both bupivacaine and tolfenamic acid. We show for the first time that bupivacaine and tolfenamic acid possess synergistic effects against bacteria when released from UHMWPE. These biomaterials may prove to be valuable tools for simultaneously managing post-operative pain and addressing periprosthetic joint infection after total joint arthroplasty.
机译:局部麻醉药和NSAID的典型的关节置换术后推注范围分别为30-400 mg和30 mg。这项研究表明,镇痛药UHMWPE可以提供布比卡因和托芬那酸的临床相关剂量。我们首次证明从UHMWPE释放时,布比卡因和甲苯酚酸具有对抗细菌的协同作用。这些生物材料可能被证明是用于在全关节置换术后同时管理术后疼痛和解决假体周围关节感染的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号